Home
Conditions
Rotavirus Vaccines

Clinical trial condition

Rotavirus Vaccines

Explore clinical trials studying Rotavirus Vaccines. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Rotavirus Vaccines trial results

Completed

ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage

NCT06882070

Conditions: Antibiotic, Antimicrobial Resistance (AMR), Diarrhea, +8 more
Locations: Noguchi Memorial Institute of Medical Research-University of Ghana Accra, Ghana

Center for Infectious Disease Research in Zambia Lusaka, Lusaka Province, Zambia

View Trial Details

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

NCT05037435

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +3 more
Locations: Perm State Medical University named after Academician E.A. Wagner Perm, Russia

View Trial Details

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

NCT00353366

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations: GSK Investigational Site Alabang, Muntinlupa City, Philippines

GSK Investigational Site Binangonan, Rizal, Philippines

GSK Investigational Site Cainta, Rizal, Philippines

GSK Investigational Site City of Muntinlupa, Philippines

View all 18 locations

View Trial Details

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

NCT03207750

Conditions: Infections, RNA Virus Infections, Reoviridae Infections, +4 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Fayetteville, Arkansas, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Daly City, California, United States

View all 47 locations

View Trial Details

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

NCT02914184

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +4 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Paramount, California, United States

GSK Investigational Site Sacramento, California, United States

View all 66 locations

View Trial Details

Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

NCT00969228

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations: GSK Investigational Site Busan, South Korea

GSK Investigational Site Daegu, South Korea

GSK Investigational Site Daegu, South Korea

GSK Investigational Site Daejeon, South Korea

View all 18 locations

View Trial Details

Completed

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

NCT01177826

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations: GSK Investigational Site Antwerp, Belgium

GSK Investigational Site Brussels, Belgium

GSK Investigational Site Brussels, Belgium

GSK Investigational Site Brussels, Belgium

View all 29 locations

View Trial Details

Completed

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

NCT00480324

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +4 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Chiba, Japan

GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Hiroshima, Japan

View all 20 locations

View Trial Details

Completed

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

NCT00432380

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

NCT01733862

Conditions: Infections, Infections, Rotavirus, RNA Virus Infections, +7 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

View Trial Details

Rotavirus Vaccines

Rotavirus Vaccines trial results

Related conditions